$Achieve Life (ACHV.US)$ Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term safety of cytisinicline, a treatment for smoking and nicotine dependence. The open-label trial involves 29 U.S. sites and aims to collect data required for a New Drug Application (NDA) submission expected in the first ...
$Achieve Life Sciences Inc(ACHV.US)$ The fortunes of the company rely entirely on a drug that is thinly patented and available for any company to use outside of the United States, making it the sole market upon which the ACHV valuation is based. This week the Biden administration signaled an incoming ban of addictive nicotine cigarettes in the United States, creating the possibility for short term lift, however analysts are likely to conclude the new laws badly undermine future revenue potential for ACHV. ...
Stock_Drift : 嗯,很好。![bar_chart 📊](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f4ca.png)
![zap ⚡](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/26a1.png)
![bar_chart 📊](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f4ca.png)